Drugs Controller General Of India Dgci
West Bengal  /  Published 25.11.21

Needle-free ZyCov-D in Covid battle soon

After Covaxin, Covishield and Sputnik V, a fourth vaccine, DNA-based vaccine ZyCov-D is likely to be in use from next month in Bengal. The Union health ministry assured the state on Wednesday that it...
By Snehamoy Chakraborty in Bolpur(Birbhum)

India  /  Published 15.11.21

SII to export 5 crore jabs

  The Indian government has permitted export of 5 crore doses of Covovax, a COVID-19 vaccine domestically produced here by the Serum Institute of India (SII), as the jab has not yet been approve...
By Payal Banerjee in New Delhi

India  /  Published 12.10.21

Covaxin gets expert panel nod for 2 to 18 age group

An expert panel of India's Central Drug Authority has recommended granting emergency use authorisation to Bharat Biotech's Covaxin for children in the 2 to 18 years age group with certain cond...
By Our Bureau, PTI in New Delhi

India  /  Published 05.10.21

Cadila: Nod for Covid jab trial

Drug firm Cadila Healthcare on Tuesday said it has received permission from the Indian drug regulator for conducting phase III trials for its two-dose COVID-19 vaccine ZyCoV-D. The company has alread...
By Our Bureau, PTI in New Delhi

India  /  Published 21.08.21

Vaccine: Nod to jab for 12-plus kids

India has approved a DNA vaccine against Covid-19 developed by the Ahmedabad-based pharmaceutical company Zydus Cadila, the country’s second homegrown vaccine against the infection and the first...
By G.S. Mudur in New Delhi


India  /  Published 11.07.21

India's vaccine drive not as bad as it looks

First the good news – and then a host of qualifications. India’s vaccination drive’s been a jerky stop-and-start affair but it’s closer to its targets than might have been expe...
By Paran Balakrishnan in New Delhi

Business  /  Published 06.07.21

Shot in arm for Panacea

Shares of Panacea Biotec on Monday closed with gains of over 5 per cent after the company announced it has received a manufacturing licence for the Sputnik V vaccine. Panacea received the manufacturi...
By Our Special Correspondent in Mumbai

India  /  Published 01.07.21

Jabs: Zydus seeks emergency nod

Zydus Cadila on Thursday said it has applied for emergency use authorisation (EUA) with the Drug Controller General of India (DCGI) for its COVID-19 vaccine ZyCoV-D. The company said it has conducted...
By Our Bureau, PTI in New Delhi

India  /  Published 29.06.21

Moderna gets DCGI nod, Cipla to import vaccines

India's drug regulator DCGI has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna's COVID-19 vaccine for restricted emergency use in the country, official sourc...
By Our Bureau, PTI in New Delhi

India  /  Published 11.06.21

Covid: Biophore seeks nod for emergency use of drug

Biophore India Pharmaceuticals on Friday said it has applied to the Drugs Controller General of India (DCGI) for obtaining emergency-use approval for Aviptadil, used in the treatment of moderate to se...
By Our Bureau, Agencies in New Delhi


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.